Wan-Shan Chen - 18 Mar 2026 Form 3 Insider Report for BELITE BIO, INC (BLTE)

Reporting relationship
Director
Issuer ticker
BLTE
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 14:12:44 UTC
Next SEC filing
02 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Wan-Shan Chen

Key filing fact

Wan-Shan Chen filed Form 3 for BELITE BIO, INC (BLTE) on 18 Mar 2026.

Key facts

  • This page summarizes Wan-Shan Chen's Form 3 filing for BELITE BIO, INC (BLTE).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 14:12.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002001438 Primary reporting owner

Chen Wan-Shan

Relationship
Director
Address
12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO
Signature
/s/ Wan-Shan Chen
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLTE holding

American depositary share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,196
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1
BLTE holding

Ordinary Share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,463
Date
18 Mar 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the Issuer.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .